PACIFIC BIOSCIENCES OF CALIF (PACB)

US69404D1081 - Common Stock

1.36  -0.11 (-7.48%)

After market: 1.3597 0 (-0.02%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to PACB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 9.01. This target is 562.5% above the current price.
PACB was analyzed by 20 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about PACB.
In the previous month the buy percentage consensus was at a similar level.
PACB was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 1.362.029.189.0121.00 - 48.53% 575.00% 562.50% 1,444.12%
Up and Down Grades
Date Firm Action Rating
2024-04-22 JP Morgan Downgrade Overweight -> Neutral
2024-04-19 Goldman Sachs Maintains Neutral -> Neutral
2024-04-18 Bernstein Maintains Outperform -> Outperform
2024-04-18 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2024-04-18 Goldman Sachs Downgrade Buy -> Neutral
2024-04-17 TD Cowen Maintains Buy -> Buy
2024-04-10 Barclays Maintains Equal-Weight -> Equal-Weight
2024-04-10 Goldman Sachs Maintains Buy -> Buy
2024-02-16 UBS Maintains Buy -> Buy
2023-12-14 Guggenheim Initiate Neutral
2023-12-14 Stephens & Co. Initiate Overweight
2023-12-13 Wolfe Research Initiate Peer Perform
2023-11-17 UBS Upgrade Neutral -> Buy
2023-11-06 Piper Sandler Maintains Neutral -> Neutral
2023-10-31 Cantor Fitzgerald Upgrade Neutral -> Overweight
2023-10-31 Canaccord Genuity Maintains Buy -> Buy
2023-10-24 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-10-16 Piper Sandler Maintains Neutral -> Neutral
2023-09-29 Barclays Maintains Equal-Weight -> Equal-Weight
2023-09-28 Bernstein Initiate Outperform
2023-09-26 Cantor Fitzgerald Reiterate Neutral -> Neutral
2023-08-22 Cantor Fitzgerald Reiterate Neutral -> Neutral
2023-08-04 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-08-03 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-06-30 Goldman Sachs Initiate Buy
2023-06-05 Canaccord Genuity Maintains Buy -> Buy
2023-05-10 Barclays Initiate Equal-Weight
2023-05-04 Morgan Stanley Maintains Equal-Weight
2023-05-03 TD Cowen Maintains Outperform
2023-05-03 Cantor Fitzgerald Maintains Neutral